======= PSMC1 =======


== Gene Information ==
  * **<color #00a2e8>Official Symbol</color>**: PSMC1
  * **<color #00a2e8>Official Name</color>**: proteasome 26S subunit, ATPase 1
  * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A
  * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5700|5700]]
  * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P62191|P62191]]
  * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=PSMC1&organism=9606|BioGRID]]
  * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PSMC1|Open PubMed]]
  * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/602706|Open OMIM]]

== Function Summary ==
  * **<color #00a2e8>Entrez Summary</color>**:  The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway.  An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the ATPase subunits, a member of the triple-A family of ATPases which have a chaperone-like activity. This subunit and a 20S core alpha subunit interact specifically with the hepatitis B virus X protein, a protein critical to viral replication. This subunit also interacts with the adenovirus E1A protein and this interaction alters the activity of the proteasome. Finally, this subunit interacts with ataxin-7, suggesting a role for the proteasome in the development of spinocerebellar ataxia type 7, a progressive neurodegenerative disorder. [provided by RefSeq, Jul 2008]. 
  * **<color #00a2e8>UniProt Summary</color>**:  Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC1 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. {ECO:0000269|PubMed:1317798}.

<button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button>
<button type='primary' size='sm' modal='GO_terms'>GO Terms</button>


<modal id='Pfam_Domains' size='lg' title='Pfam Domains'>
|AAA 2|
|AAA|
</modal>

<modal id='GO_terms' size='lg' title='GO Terms'>
|proteasome-activating ATPase activity|
|proteasome regulatory particle, base subcomplex|
|proteasome accessory complex|
|TBP-class protein binding|
|proteasome complex|
|regulation of cellular amino acid metabolic process|
|regulation of hematopoietic stem cell differentiation|
|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent|
|regulation of transcription from RNA polymerase II promoter in response to hypoxia|
|antigen processing and presentation of exogenous peptide antigen via MHC class I|
|regulation of cellular amine metabolic process|
|NIK/NF-kappaB signaling|
|anaphase-promoting complex-dependent catabolic process|
|regulation of hematopoietic progenitor cell differentiation|
|negative regulation of G2/M transition of mitotic cell cycle|
|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|
|interleukin-1-mediated signaling pathway|
|Wnt signaling pathway, planar cell polarity pathway|
|antigen processing and presentation of peptide antigen via MHC class I|
|negative regulation of cell cycle G2/M phase transition|
|positive regulation of proteasomal protein catabolic process|
|regulation of establishment of planar polarity|
|stimulatory C-type lectin receptor signaling pathway|
|innate immune response activating cell surface receptor signaling pathway|
|regulation of stem cell differentiation|
|tumor necrosis factor-mediated signaling pathway|
|regulation of transcription from RNA polymerase II promoter in response to stress|
|positive regulation of proteolysis involved in cellular protein catabolic process|
|regulation of DNA-templated transcription in response to stress|
|non-canonical Wnt signaling pathway|
|positive regulation of cellular protein catabolic process|
|positive regulation of canonical Wnt signaling pathway|
|regulation of cellular ketone metabolic process|
|Fc-epsilon receptor signaling pathway|
|negative regulation of canonical Wnt signaling pathway|
|cellular response to interleukin-1|
|T cell receptor signaling pathway|
|antigen processing and presentation of exogenous peptide antigen|
|positive regulation of Wnt signaling pathway|
|regulation of mRNA stability|
|regulation of morphogenesis of an epithelium|
|antigen processing and presentation of exogenous antigen|
|regulation of proteasomal protein catabolic process|
|regulation of RNA stability|
|cellular response to hypoxia|
|antigen processing and presentation of peptide antigen|
|regulation of G2/M transition of mitotic cell cycle|
|cellular response to decreased oxygen levels|
|response to interleukin-1|
|regulation of mRNA catabolic process|
|negative regulation of neuron death|
|negative regulation of Wnt signaling pathway|
|regulation of cell cycle G2/M phase transition|
|negative regulation of mitotic cell cycle phase transition|
|cellular response to oxygen levels|
|regulation of proteolysis involved in cellular protein catabolic process|
|positive regulation of protein catabolic process|
|antigen processing and presentation|
|negative regulation of cell cycle phase transition|
|protein folding|
|innate immune response-activating signal transduction|
|ATPase activity|
|cellular response to tumor necrosis factor|
|Fc receptor signaling pathway|
|regulation of cellular protein catabolic process|
|regulation of animal organ morphogenesis|
|activation of innate immune response|
|response to tumor necrosis factor|
|regulation of canonical Wnt signaling pathway|
|protein deubiquitination|
|antigen receptor-mediated signaling pathway|
|protein modification by small protein removal|
|protein polyubiquitination|
|negative regulation of mitotic cell cycle|
|regulation of neuron death|
|proteasome-mediated ubiquitin-dependent protein catabolic process|
|negative regulation of cell cycle process|
|regulation of mRNA metabolic process|
|positive regulation of innate immune response|
|response to hypoxia|
|proteasomal protein catabolic process|
|positive regulation of proteolysis|
|response to decreased oxygen levels|
|cell-cell signaling by wnt|
|Wnt signaling pathway|
|regulation of Wnt signaling pathway|
|post-translational protein modification|
|positive regulation of response to biotic stimulus|
|positive regulation of cellular catabolic process|
|MAPK cascade|
|response to oxygen levels|
|regulation of protein catabolic process|
|signal transduction by protein phosphorylation|
|regulation of mitotic cell cycle phase transition|
|regulation of small molecule metabolic process|
|cell surface receptor signaling pathway involved in cell-cell signaling|
|positive regulation of catabolic process|
|regulation of cell cycle phase transition|
|immune response-activating cell surface receptor signaling pathway|
|regulation of hemopoiesis|
|regulation of innate immune response|
|positive regulation of defense response|
|immune response-regulating cell surface receptor signaling pathway|
|positive regulation of multi-organism process|
|regulation of response to biotic stimulus|
|posttranscriptional regulation of gene expression|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|immune response-activating signal transduction|
|negative regulation of cell cycle|
|proteolysis involved in cellular protein catabolic process|
|immune response-regulating signaling pathway|
|positive regulation of response to external stimulus|
|cellular protein catabolic process|
|activation of immune response|
|regulation of mitotic cell cycle|
|cytokine-mediated signaling pathway|
|protein catabolic process|
|protein ubiquitination|
|regulation of proteolysis|
|regulation of cell cycle process|
|regulation of defense response|
|protein modification by small protein conjugation|
|regulation of multi-organism process|
|regulation of cellular catabolic process|
|positive regulation of immune response|
|cellular macromolecule catabolic process|
|protein phosphorylation|
|protein modification by small protein conjugation or removal|
|regulation of catabolic process|
|negative regulation of cell death|
|cellular response to cytokine stimulus|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|regulation of anatomical structure morphogenesis|
|regulation of response to external stimulus|
|response to cytokine|
|cell-cell signaling|
|regulation of immune response|
|positive regulation of immune system process|
|response to abiotic stimulus|
|regulation of cell cycle|
|negative regulation of signal transduction|
|proteolysis|
|transmembrane transport|
|phosphorylation|
|negative regulation of cell communication|
|negative regulation of signaling|
|RNA binding|
|regulation of response to stress|
|ATP binding|
|positive regulation of cellular protein metabolic process|
|negative regulation of response to stimulus|
|positive regulation of signal transduction|
|regulation of immune system process|
|regulation of cell death|
|intracellular signal transduction|
|cellular response to stress|
|positive regulation of protein metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|regulation of cell differentiation|
|positive regulation of cell communication|
|positive regulation of signaling|
|membrane|
</modal>
\\

 === CRISPR Data ===
<button type='default' size='small' modal='Compound_Hit'>Compound Hit</button>
<button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button>
<button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button>

<modal id='Compound_Hit' size='lg' title='Compound Hit'>
No hits were found.
</modal>

<modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'>
^Gene^Correlation^
|[[:human genes:d:dtl|DTL]]|0.576|
|[[:human genes:p:psma6|PSMA6]]|0.574|
|[[:human genes:z:zfand5|ZFAND5]]|0.569|
|[[:human genes:p:psmd1|PSMD1]]|0.565|
|[[:human genes:t:tbc1d3c|TBC1D3C]]|0.548|
|[[:human genes:t:tbc1d3h|TBC1D3H]]|0.548|
|[[:human genes:t:tbc1d3g|TBC1D3G]]|0.547|
|[[:human genes:p:pan3|PAN3]]|0.536|
|[[:human genes:s:smg7|SMG7]]|0.535|
|[[:human genes:p:psmd11|PSMD11]]|0.534|
|[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.532|
|[[:human genes:z:znf106|ZNF106]]|0.531|
|[[:human genes:t:tceb3c|TCEB3C]]|0.53|
|[[:human genes:t:tceb3cl|TCEB3CL]]|0.527|
|[[:human genes:c:c1qtnf9b|C1QTNF9B]]|0.517|
|[[:human genes:p:psmb4|PSMB4]]|0.517|
|[[:human genes:c:chd4|CHD4]]|0.513|
|[[:human genes:s:slc4a1|SLC4A1]]|0.51|
|[[:human genes:p:psmc2|PSMC2]]|0.507|
|[[:human genes:c:cdc73|CDC73]]|0.506|
|[[:human genes:r:rpl35|RPL35]]|0.505|
|[[:human genes:r:rps28|RPS28]]|0.5|
|[[:human genes:t:tbc1d3f|TBC1D3F]]|0.497|
|[[:human genes:v:vasn|VASN]]|0.497|
|[[:human genes:t:tbc1d3|TBC1D3]]|0.495|
|[[:human genes:m:myo1h|MYO1H]]|0.495|
|[[:human genes:t:tbc1d3k|TBC1D3K]]|0.492|
|[[:human genes:t:tbc1d3e|TBC1D3E]]|0.492|
|[[:human genes:t:tbc1d3i|TBC1D3I]]|0.492|
|[[:human genes:t:tbc1d3l|TBC1D3L]]|0.491|
|[[:human genes:k:kif3c|KIF3C]]|0.49|
|[[:human genes:u:upf1|UPF1]]|0.489|
|[[:human genes:t:ticrr|TICRR]]|0.487|
|[[:human genes:p:psmc6|PSMC6]]|0.486|
|[[:human genes:c:c14orf93|C14orf93]]|0.486|
|[[:human genes:p:psmd6|PSMD6]]|0.485|
|[[:human genes:m:med14|MED14]]|0.483|
|[[:human genes:a:atp13a1|ATP13A1]]|0.483|
|[[:human genes:c:cope|COPE]]|0.481|
|[[:human genes:c:cdc6|CDC6]]|0.481|
|[[:human genes:h:hist2h2bf|HIST2H2BF]]|0.48|
|[[:human genes:s:supt6h|SUPT6H]]|0.48|
|[[:human genes:c:col2a1|COL2A1]]|0.48|
|[[:human genes:t:tfip11|TFIP11]]|0.479|
|[[:human genes:h:hap1|HAP1]]|0.478|
|[[:human genes:r:rad21|RAD21]]|0.477|
|[[:human genes:c:ciapin1|CIAPIN1]]|0.475|
|[[:human genes:c:ccna2|CCNA2]]|0.472|
|[[:human genes:n:nupl1|NUPL1]]|0.472|
|[[:human genes:p:pan2|PAN2]]|0.471|
|[[:human genes:c:cbwd3|CBWD3]]|0.471|
|[[:human genes:d:ddtl|DDTL]]|0.471|
|[[:human genes:s:ssh2|SSH2]]|0.471|
|[[:human genes:c:ccdc64b|CCDC64B]]|0.469|
|[[:human genes:p:psma7|PSMA7]]|0.469|
|[[:human genes:r:rrn3|RRN3]]|0.469|
|[[:human genes:p:psmd3|PSMD3]]|0.468|
|[[:human genes:s:snrpa1|SNRPA1]]|0.467|
|[[:human genes:c:cbwd5|CBWD5]]|0.467|
|[[:human genes:c:chaf1a|CHAF1A]]|0.467|
|[[:human genes:r:rps9|RPS9]]|0.466|
|[[:human genes:r:rplp1|RPLP1]]|0.465|
|[[:human genes:c:cactin|CACTIN]]|0.465|
|[[:human genes:p:psmb1|PSMB1]]|0.463|
|[[:human genes:p:psmc4|PSMC4]]|0.462|
|[[:human genes:m:myb|MYB]]|0.462|
|[[:human genes:c:copb1|COPB1]]|0.461|
|[[:human genes:c:cbwd6|CBWD6]]|0.46|
|[[:human genes:r:rps2|RPS2]]|0.459|
|[[:human genes:s:sec13|SEC13]]|0.459|
|[[:human genes:s:syt9|SYT9]]|0.458|
|[[:human genes:p:psma1|PSMA1]]|0.457|
|[[:human genes:r:rbm39|RBM39]]|0.456|
|[[:human genes:x:xylt2|XYLT2]]|0.456|
|[[:human genes:p:psmd13|PSMD13]]|0.455|
|[[:human genes:s:sema6b|SEMA6B]]|0.455|
|[[:human genes:r:rps5|RPS5]]|0.454|
|[[:human genes:w:wdr87|WDR87]]|0.454|
|[[:human genes:r:rpl26|RPL26]]|0.454|
|[[:human genes:g:golga8o|GOLGA8O]]|0.451|
|[[:human genes:a:ankle2|ANKLE2]]|0.451|
|[[:human genes:s:supt5h|SUPT5H]]|0.45|
|[[:human genes:c:cep192|CEP192]]|0.45|
|[[:human genes:p:pole|POLE]]|0.449|
|[[:human genes:p:psmc3|PSMC3]]|0.449|
|[[:human genes:b:bcl2l1|BCL2L1]]|0.448|
|[[:human genes:r:rrp15|RRP15]]|0.447|
|[[:human genes:c:chmp2a|CHMP2A]]|0.446|
|[[:human genes:e:exosc3|EXOSC3]]|0.446|
|[[:human genes:r:rpsa|RPSA]]|0.446|
|[[:human genes:m:mdm2|MDM2]]|0.445|
|[[:human genes:m:mms22l|MMS22L]]|0.445|
|[[:human genes:p:ppm1d|PPM1D]]|0.444|
|[[:human genes:p:plk1|PLK1]]|0.443|
|[[:human genes:r:rpl8|RPL8]]|0.443|
|[[:human genes:g:golga6a|GOLGA6A]]|0.443|
|[[:human genes:c:ctage4|CTAGE4]]|0.442|
|[[:human genes:c:copg1|COPG1]]|0.442|
|[[:human genes:p:pwp2|PWP2]]|0.441|
|[[:human genes:a:atp6v1c1|ATP6V1C1]]|0.44|
|[[:human genes:z:znf830|ZNF830]]|0.44|
|[[:human genes:r:rps12|RPS12]]|0.439|
|[[:human genes:p:psmd2|PSMD2]]|0.439|
|[[:human genes:p:psmc5|PSMC5]]|0.439|
|[[:human genes:m:myh2|MYH2]]|0.439|
|[[:human genes:l:lrr1|LRR1]]|0.438|
|[[:human genes:i:igfn1|IGFN1]]|0.438|
|[[:human genes:p:polr2j3|POLR2J3]]|0.438|
|[[:human genes:r:rpl14|RPL14]]|0.437|
|[[:human genes:c:ctr9|CTR9]]|0.435|
|[[:human genes:w:wdr43|WDR43]]|0.435|
|[[:human genes:m:mt1e|MT1E]]|0.435|
|[[:human genes:z:znf655|ZNF655]]|0.435|
|[[:human genes:a:akirin2|AKIRIN2]]|0.434|
|[[:human genes:r:rad51|RAD51]]|0.434|
|[[:human genes:p:psmb2|PSMB2]]|0.434|
|[[:human genes:s:smg1|SMG1]]|0.432|
|[[:human genes:n:nol12|NOL12]]|0.431|
|[[:human genes:n:nbpf10|NBPF10]]|0.431|
|[[:human genes:n:nbpf16|NBPF16]]|0.431|
|[[:human genes:r:rpl6|RPL6]]|0.43|
|[[:human genes:a:acsf2|ACSF2]]|0.43|
|[[:human genes:r:ranbp2|RANBP2]]|0.43|
|[[:human genes:o:orc6|ORC6]]|0.429|
|[[:human genes:t:twistnb|TWISTNB]]|0.429|
|[[:human genes:s:s1pr4|S1PR4]]|0.427|
|[[:human genes:k:kctd17|KCTD17]]|0.427|
|[[:human genes:h:hcfc1|HCFC1]]|0.427|
|[[:human genes:n:nup133|NUP133]]|0.426|
|[[:human genes:k:kpnb1|KPNB1]]|0.426|
|[[:human genes:c:cdca3|CDCA3]]|0.425|
|[[:human genes:d:dnm2|DNM2]]|0.424|
|[[:human genes:o:or10g3|OR10G3]]|0.423|
|[[:human genes:i:iscu|ISCU]]|0.423|
|[[:human genes:c:c15orf52|C15orf52]]|0.422|
|[[:human genes:c:chmp4b|CHMP4B]]|0.422|
|[[:human genes:d:ddx21|DDX21]]|0.422|
|[[:human genes:f:fam160a1|FAM160A1]]|0.42|
|[[:human genes:m:mbtd1|MBTD1]]|0.42|
|[[:human genes:d:dnttip2|DNTTIP2]]|0.42|
|[[:human genes:d:dhx38|DHX38]]|0.419|
|[[:human genes:t:terf2|TERF2]]|0.419|
|[[:human genes:t:tsg101|TSG101]]|0.418|
|[[:human genes:n:npipb5|NPIPB5]]|0.417|
|[[:human genes:g:golga6l6|GOLGA6L6]]|0.417|
|[[:human genes:p:pola2|POLA2]]|0.417|
|[[:human genes:l:lad1|LAD1]]|0.416|
|[[:human genes:r:rpa2|RPA2]]|0.416|
|[[:human genes:c:cgb2|CGB2]]|0.416|
|[[:human genes:u:ubap1|UBAP1]]|0.416|
|[[:human genes:s:slc6a17|SLC6A17]]|0.415|
|[[:human genes:n:napa|NAPA]]|0.415|
|[[:human genes:d:dync1i2|DYNC1I2]]|0.415|
|[[:human genes:p:paf1|PAF1]]|0.415|
|[[:human genes:r:rrm1|RRM1]]|0.414|
|[[:human genes:r:rpl7l1|RPL7L1]]|0.414|
|[[:human genes:u:utp3|UTP3]]|0.414|
|[[:human genes:c:ctage9|CTAGE9]]|0.414|
|[[:human genes:a:adrm1|ADRM1]]|0.414|
|[[:human genes:p:pde4dip|PDE4DIP]]|0.413|
|[[:human genes:p:psmd14|PSMD14]]|0.413|
|[[:human genes:t:tpx2|TPX2]]|0.412|
|[[:human genes:d:dock6|DOCK6]]|0.411|
|[[:human genes:m:med17|MED17]]|0.411|
|[[:human genes:u:usp5|USP5]]|0.41|
|[[:human genes:c:cdt1|CDT1]]|0.41|
|[[:human genes:p:pla2g4f|PLA2G4F]]|0.409|
|[[:human genes:i:ik|IK]]|0.408|
|[[:human genes:k:kiaa1211|KIAA1211]]|0.408|
|[[:human genes:c:ckap5|CKAP5]]|0.408|
|[[:human genes:f:fam231a|FAM231A]]|0.407|
|[[:human genes:x:xrcc6|XRCC6]]|0.407|
|[[:human genes:e:exosc9|EXOSC9]]|0.407|
|[[:human genes:f:fam231c|FAM231C]]|0.407|
|[[:human genes:t:top1mt|TOP1MT]]|0.405|
|[[:human genes:n:narfl|NARFL]]|0.405|
|[[:human genes:s:sap30bp|SAP30BP]]|0.405|
|[[:human genes:g:gid4|GID4]]|0.405|
|[[:human genes:n:npipb8|NPIPB8]]|0.404|
|[[:human genes:a:aatf|AATF]]|0.404|
|[[:human genes:p:prpf19|PRPF19]]|0.403|
|[[:human genes:a:akt1s1|AKT1S1]]|0.402|
|[[:human genes:c:cdc45|CDC45]]|0.402|
|[[:human genes:g:golga6l3|GOLGA6L3]]|0.402|
|[[:human genes:h:hivep3|HIVEP3]]|0.402|
|[[:human genes:p:pold1|POLD1]]|0.402|
|[[:human genes:n:nup85|NUP85]]|0.402|
|[[:human genes:p:psmd7|PSMD7]]|0.401|
|[[:human genes:r:rfc1|RFC1]]|0.401|
|[[:human genes:n:nop16|NOP16]]|0.401|
|[[:human genes:s:sfpq|SFPQ]]|0.4|
|[[:human genes:r:rpl34|RPL34]]|0.4|
</modal>

<modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'>
Global Fraction of Cell Lines Where Essential: 97/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|3/28|
|blood|8/28|
|bone|6/26|
|breast|7/33|
|central nervous system|6/56|
|cervix|0/4|
|colorectal|2/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|1/16|
|kidney|4/21|
|liver|2/20|
|lung|6/75|
|lymphocyte|5/16|
|ovary|4/26|
|pancreas|2/24|
|peripheral nervous system|4/16|
|plasma cell|9/15|
|prostate|0/1|
|skin|2/24|
|soft tissue|2/9|
|thyroid|0/2|
|upper aerodigestive|2/22|
|urinary tract|1/29|
|uterus|0/5|
</modal>

== Essentiality in NALM6  ==
    * **<color #00a2e8>Essentiality Rank</color>**: 1724
    * **<color #00a2e8>Expression level (log2 read counts)</color>**: 6.79 
<button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button>
<modal id='Dist_expr' size='lg' title='PSMC1 Expression in NALM6 Cells: 6.79'>
{{:chemogenomics:nalm6 dist.png?nolink |}}
</modal>